DANCR201/miR-216a/端粒酶激活的信号轴调控动脉粥样硬化血管衰老和斑块稳定性的分子与临床研究
批准号:
82070373
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
张伟丽
依托单位:
学科分类:
冠状动脉性心脏病
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
张伟丽
中文摘要
血管老化是动脉粥样硬化的重要特征。前期工作通过全转录组测序发现lncRNA DANCR201在冠脉混合斑块组患者低表达,且在老年患者外周血中表达水平显著降低;细胞定位在斑块部位内皮细胞,并发现DANCR201竞争结合miR-216a,调控下游靶点端粒酶活性。基于此,提出科学假设:DANCR201/miR-216a/端粒酶信号轴调控血管老化和斑块进展。本项目拟解决问题1: 通过基因过表达、siRNA阻断技术以及内皮细胞特异敲除DANCR201-/-、miR-216a-/-小鼠模型,明确DANCR201通过ceRNA方式募集miR-216a,调控端粒酶活性,进而影响动脉粥样硬化血管衰老和斑块稳定的分子机制;2:检测冠脉钙化前瞻性队列外周血DANCR201和miR-216a表达与血管内皮功能及斑块特征的关系。这将为阐明lncRNAs调控血管内皮炎性衰老和动脉粥样硬化斑块稳定性的机制提供新靶点。
英文摘要
Endothelial senescence related vessel dysfunction is important risk factor for the development of atherosclerosis and cardiovascular diseases. Recently, long noncoding RNA (lncRNAs) has aroused growing interests in life sciences, but the role of which in atherosclerotic vessel dysfunction remains largely unknown. ..With the use of whole-blood transcriptome sequencing technique, our preliminary data identified a new lncRNA, DANCR201, which showed a significantly lower expression in patients with mixed plaques, compared with those patents with calcification plaques and healthy subjects. Stable expression of DANCR201 by lentivirus in human umbilical vein endothelial cell (HUVECs) significantly improved the cell viability such as cell proliferation, migration and inhibited monocytes adhesion to endothelial cell monolayers. In addition, analysis of miRNA-lncRNA interactions indicated that DANCR201 contains a candidate binding site of miR-216a between 764 and 770 bps. Furthermore, we also found that miR-216a triggered the endothelial senescence and promoted the endothelial inflammation by activating the NF-κB signaling pathway. Based on these interesting preliminary findings, we proposed the hypothesis that DANCR201 may regulate atherosclerotic vascular senescence and plaque instability through NF-κB/telomerase pathway by sponging miR-216a...In the present project, we aimed to (1) investigate whether DANCR201 can regulate the activation of telomerase activity by sponging miR-216a and modulate the endothelial senescence related dysfunctions in vitro and vivo, via the cellular model of lentivirus overexpression, or siRNA technique, as well as the ApoE-/- atherosclerotic model of mice with endothelial cell-specific knockdown of DANCR201-/- and miR-216a-/-;(2) investigate the relationship between circulating DANCR201, miR-216a levels and progression of coronary artery plaques and the risk of future cardiovascular diseases in a perspective cohort of coronary heart disease patients. This study will provide new targets for the diagnosis and treatment of aging-related atherosclerotic diseases.
血管内皮细胞构成心血管系统的内膜,血管内膜损伤和修复平衡紊乱可引起血管形态功能异常,是促进动脉粥样硬化形成和斑块进展的重要因素。因此,阐明抑制血管内皮细胞早期炎症反应和功能损伤的调控机制,对预防和延缓动脉粥样硬化进程至关重要。本研究建立冠状动脉粥样硬化斑块检测的前瞻性研究人群,进行冠状动脉CT造影(CCTA),读取三维重建冠脉CT图像,获得冠脉钙化积分、管腔狭窄程度和斑块成分等,并进行患者随访。根据CCTA结果将人群分为:无斑块健康对照组和混合斑块组。我们用外周血全转录组测序技术,首次鉴别一种lncRNA分子DANCR-201在冠脉混合斑块组患者外周血低表达。细胞表达谱显示DANCR-201在内皮细胞中高表达并调控内皮细胞功能。. 我们构建内皮细胞特异敲除DANCR-201的动脉粥样硬化小鼠模型动物实验,深入研究了DANCR-201的功能。DANCR-201敲除显著促进了小鼠主动脉的斑块面积增长,斑块不稳定性指数增加,并促进单核细胞向动脉内皮细胞的粘附功能显著增加。我们通过RNA纯化的染色质免疫共沉淀和测序技术发现DANCR-201 可靶向结合核糖体蛋白L22(ribosomal protein L22,RPL22)基因启动子,抑制其表达。DANCR-201通过靶向抑制RPL22调控内皮细胞中的粘附作用,在动脉粥样硬化斑块疾病进展及斑块稳定性中起到保护作用,为预防和延缓动脉粥样硬化进展提供了新靶点。
Noggin及其共表达lncRNAs调控单核巨噬细胞表型分化及其在动脉硬化血管重塑中的机制与临床研究
-
批准号:81873492
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2018
-
负责人:张伟丽
-
依托单位:
端粒酶激活调控单核巨噬细胞亚型的分化及其在动脉粥样硬化血管重塑中的作用机制
-
批准号:81670338
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2016
-
负责人:张伟丽
-
依托单位:
国内基金
海外基金